Results 11 to 20 of about 55,784 (291)

Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease

open access: yesTherapeutic Advances in Respiratory Disease, 2017
Chronic inflammation plays a central role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, there are no effective anti-inflammatory pharmacologic therapies available for COPD so far.
Shilin Qiu, Xiaoning Zhong
doaj   +3 more sources

The effect of macrolides on allergic rhinitis versus chronic rhinosinusitis- an in-vitro study [PDF]

open access: yes, 2009
PhDBackground The mechanisms of the rhinitic process are complex. Previous studies upon nasal epithelial cells have begun to investigate rhinitis.
Kuchai, Romana
core   +4 more sources

Macrolides from rare actinomycetes:Structures and bioactivities [PDF]

open access: yes, 2022
Rare actinomycetes are a source of numerous diverse, biologically active secondary metabolites, including macrolides, which have been shown to display several antibiotic activities.
Threadgill, Michael D.   +7 more
core   +1 more source

macrolides

open access: yes, 2022
Archive of macrolides containing sub-folders named after each compound and its net charge. Every compound's folder contains a total of 20 files distributed into three sub-directories reporting QM (QM/), FF (FF/), and MD (MD ...
Giuliano Malloci (2060875)   +5 more
core   +1 more source

Investigating the Structure-Activity Relationship of Laulimalides Marine Macrolides as Promising Inhibitors for SARS-CoV-2 Main Protease (Mpro) [PDF]

open access: yes, 2023
SARS-CoV-2, the new coronavirus variant is a world-wide health crisis. Over spans of human history, preparations derived from natural products have always been recognized as a preliminary source of medications.
Florbela , Pereira   +8 more
core   +1 more source

Macrolides et pneumopathies chroniques [Macrolides antibiotics and chronic pulmonary disease]

open access: yes, 2022
Macrolides are commonly used antibiotics due to their broad spectrum of activity and good bioavailability. More recently, they have been shown to be effective in certain chronic lung diseases by reducing exacerbation frequency.
Von Garnier, C., Mouraux, S., Nater, A.
core   +1 more source

Macrolides versus placebo for chronic asthma. [PDF]

open access: yes, 2021
BACKGROUND: Asthma is a chronic disease in which inflammation of the airways causes symptomatic wheezing, coughing and difficult breathing. Macrolides are antibiotics with antimicrobial and anti-inflammatory activities that have been explored for the ...
Giovanni Ferrara   +15 more
core   +4 more sources

Proportion of prescribed macrolides among all macrolides as a function of age during 2013–2018.

open access: yes, 2023
Proportion of prescribed macrolides among all macrolides as a function of age during 2013–2018.
Satoshi Ide (3498026)   +9 more
core   +1 more source

The Renaissance of Spiramycin in Clinical Practice

open access: yesАнтибиотики и Химиотерапия, 2023
Spiramycin is a natural 16-membered macrolide antibiotic that has been used in clinical practice for about 70 years. Despite long-term use, spiramycin retains its position in clinical practice; the resistance of the main respiratory and urogenital ...
S. V. Yakovlev, М. Р. Suvorova
doaj   +1 more source

Placing Ureaplasma within the Context of Bronchopulmonary Dysplasia Endotypes and Phenotypes

open access: yesChildren, 2023
Different pathophysiological pathways (endotypes), leading to very preterm birth may result in distinct clinical phenotypes of bronchopulmonary dysplasia (BPD). Ureaplasma is a unique player in the pathogenesis of BPD.
Karen Van Mechelen   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy